Tubridy Karen L 4
4 · Akebia Therapeutics, Inc. · Filed Apr 12, 2019
Insider Transaction Report
Form 4
Tubridy Karen L
SVP, Chief Development Officer
Transactions
- Disposition to Issuer
Common Stock
2019-04-11$7.70/sh−6,075$46,778→ 55,324 total
Footnotes (1)
- [F1]The proceeds from the disposition of these shares are to be used by the reporting person to cover tax liabilities associated with previously vested restricted stock units.